Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
---|---|---|---|---|---|---|
Q3 2024 | 20 | 427,325 | PTGX, RAPP, LEGN, CTNM | 13F-HR | 11/13/2024 | 000090445424000604 |
Q2 2024 | 20 | 400,670 | PTGX, Rapport Therapeutics, Inc., CVRX, LEGN | 13F-HR | 8/9/2024 | 000090445424000451 |
Q1 2024 | 22 | 4,413,028 | KVUE, FUSN, CVRX, PTGX | 13F-HR | 5/10/2024 | 000090445424000285 |
Q4 2023 | 23 | 4,386,242 | KVUE, CVRX, PTGX, LEGN | 13F-HR | 2/13/2024 | 000090445424000151 |
Q3 2023 | 24 | 271,470 | LEGN, CVRX, PTGX, MGTX | 13F-HR | 11/9/2023 | 000090445423000600 |
Q2 2023 | 22 | 322,070 | PTGX, LEGN, CVRX, MGTX | 13F-HR | 8/2/2023 | 000090445423000459 |
Q1 2023 | 23 | 307,422 | LEGN, PTGX, MGTX, CVRX | 13F-HR | 5/11/2023 | 000090445423000307 |
Q4 2022 | 22 | 343,711 | LEGN, CVRX, MGTX, FATE | 13F-HR | 2/9/2023 | 000156761923002139 |
Q3 2022 | 22 | 339,823 | FATE, LEGN, PRCT, CVRX | 13F-HR | 11/10/2022 | 000156761922019556 |
Q2 2022 | 22 | 391,451 | LEGN, FATE, ARWR, PRCT | 13F-HR | 8/10/2022 | 000156761922015421 |
Q1 2022 | 22 | 528,967 | FATE, LEGN, PTGX, ARWR | 13F-HR | 5/9/2022 | 000156761922009807 |
Q4 2021 | 24 | 878,419 | ARWR, FATE, PTGX, LEGN | 13F-HR | 2/14/2022 | 000156761922004279 |
Q3 2021 | 25 | 1,139,968 | ILMN, ARWR, FATE, LEGN | RESTATEMENT | 11/16/2021 | 000156761921020557 |